The French Society for Pharmacy Oncology's commentary on the article by Iannopollo M., published in April 2026 and titled "Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy, subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal"
